Word

CELLAÏON

Status

Registered

Status Code

700

Status Date

Tuesday, March 5, 2024

Serial Number

79346877

Registration Number

7318105

Registration Date

Tuesday, March 5, 2024

Mark Type

4000

Filing Date

Thursday, June 16, 2022

Published for Opposition

Tuesday, December 19, 2023

Trademark Owner History

Cellaïon, société anonyme - Original Registrant

Classifications

5 Cells originating from human tissue, for medical, clinical or veterinary use, namely, liver derived cells and stem cells or liver progenitor cells; pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of diseases that require cell therapy medicinal products, namely, liver diseases, chronic biliary diseases, cholestatic diseases, age-related diseases, bone and cartilage disorders, pancreatic diseases, kidney diseases, pulmonary diseases, cardiovascular diseases, eye diseases, ocular diseases, organ injury, organ failure, blood coagulation disorders, Clarkson disease, diabetes, skin diseases, cancer, metabolic diseases, inflammatory diseases, inflammation, neurodegenerative diseases, fibrotic diseases, proliferative diseases, infectious diseases, autoimmune diseases, diseases with unwanted immune response, sepsis, sepsis induced diseases, cellular senescence; surgical implants comprised of living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; transplants being living tissue in the form of liver derived cells and stem cells or liver progenitor cells; live organs and tissues for surgical purpose in the field of liver derived cells and stem cells or liver progenitor cells; surgical implants comprising living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; cell-based pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of liver diseases, chronic biliary diseases, cholestatic diseases, age-related diseases, bone and cartilage disorders, pancreatic diseases, kidney diseases, pulmonary diseases, cardiovascular diseases, eye diseases, ocular diseases, organ injury, organ failure, blood coagulation disorders, Clarkson disease, diabetes, skin diseases, cancer, metabolic diseases, inflammatory diseases, inflammation, neurodegenerative diseases, fibrotic diseases, proliferative diseases, infectious diseases, autoimmune diseases, diseases with unwanted immune response, sepsis, sepsis induced diseases, cellular senescence

42 Biomedical research and development services in relation to the testing of biological samples to determine the presence and activity of stem cells, progenitor cells and liver cells, in particular, liver stem cells and liver progenitor cells

Trademark Events

Mar 11, 2024

Notification Of Possible Opposition - Processed By Ib

Mar 5, 2024

Notice Of Registration Confirmation Emailed

Mar 5, 2024

Registered-Principal Register

Feb 21, 2024

Notification Of Possible Opposition Sent To Ib

Feb 21, 2024

Notification Of Possible Opposition Created, To Be Sent To Ib

Dec 21, 2023

Teas Change Of Correspondence Received

Dec 21, 2023

Teas Change Of Domestic Representatives Address

Dec 21, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 21, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 19, 2023

Notification Processed By Ib

Dec 19, 2023

Official Gazette Publication Confirmation E-Mailed

Dec 19, 2023

Published For Opposition

Nov 29, 2023

Notification Of Possible Opposition Sent To Ib

Nov 29, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Nov 29, 2023

Notification Of Notice Of Publication E-Mailed

Nov 16, 2023

Approved For Pub - Principal Register

Oct 21, 2023

Teas/Email Correspondence Entered

Oct 20, 2023

Correspondence Received In Law Office

Oct 20, 2023

Teas Response To Office Action Received

Jun 26, 2023

Refusal Processed By Ib

Jun 4, 2023

New Representative At Ib Received

Jun 3, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Jun 3, 2023

Refusal Processed By Mpu

May 23, 2023

Limitation From The Ib - Request Exam Review

Apr 6, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Apr 5, 2023

Non-Final Action Written

Mar 29, 2023

Assigned To Examiner

Mar 19, 2023

Limitation Of Goods Received From Ib

Dec 1, 2022

Correction From Ib Entered - No Review Required

Sep 19, 2022

Correction Transaction Received From Ib

Aug 16, 2022

Application Filing Receipt Mailed

Aug 12, 2022

New Application Office Supplied Data Entered

Aug 11, 2022

Sn Assigned For Sect 66a Appl From Ib